Advertisement

Topics

Adalimumab biosimilar Idacio launched in Germany

07:25 EDT 17 May 2019 | Generics and Biosimilars Initiative

Fresenius Kabi, one of the independently operated business segments of global healthcare group Fresenius, announced on 3 May 2019 that it had launched its adalimumab biosimilar Idacio in Germany.

Original Article: Adalimumab biosimilar Idacio launched in Germany

NEXT ARTICLE

More From BioPortfolio on "Adalimumab biosimilar Idacio launched in Germany"

Advertisement
Quick Search
Advertisement
Advertisement